- JP-listed companies
- SAWAI GROUP HOLDINGS Co., Ltd.
- Income statement
SAWAI GROUP HOLDINGS Co., Ltd. (4887) Income statement
Market cap
¥224.9B
P/E ratio
10.6x
Sawai Group Holdings manufactures and sells prescription and over-the-counter pharmaceuticals through its domestic subsidiaries in Japan.
| 2022/03 | 2023/03 | 2024/03 | 2025/03 | 2026/03 | |
| Revenue | 193,816 | 200,344 | 176,862 | 189,024 | 201,676 |
| Revenue growth (%) | - | ||||
| Cost of revenue | 127,164 | 137,711 | 122,543 | 132,673 | 142,882 |
| Gross profit | 66,652 | 62,633 | 54,319 | 56,352 | 58,793 |
| Gross margin (%) | |||||
| Operating margin (%) | |||||
| Operating expenses | 46,690 | 30,156 | 23,244 | 23,518 | 26,056 |
| Operating income | -35,888 | 16,984 | 18,620 | 4,050 | 15,894 |
| Income before tax | -36,214 | 16,789 | 18,262 | 3,161 | 14,273 |
| Pretax margin (%) | -18.7 | 8.4 | 10.3 | 1.7 | 7.1 |
| Provision for income taxes | 5,710 | 3,954 | 5,583 | 988 | 2,737 |
| Effective tax rate (%) | |||||
| Net income | -28,269 | 12,667 | 13,695 | 11,969 | 10,438 |
| Earnings per share | -645.53 | 289.25 | 312.67 | 96.54 | 90.39 |
| Diluted EPS | -645.53 | 288.6 | 311.79 | 96.25 | 90.1 |
| Dividend payout ratio (%) | - | ||||
| Dividend per share | 130 | 130 | 130 | - | 55 |